인쇄하기
취소
|
The Fair Trade Commission(FTC) reportedly investigated a Korean pharma B and a multinational pharma L last week and a Korean pharma D and a multinational pharma A on the 18th.
The investigation was about ‘pay-for-delay’; the FTC has once announced a policy to investigate actual conditions about ‘pay-for-delay deals’ on 71 original and generic medicine companies.
Pay-for-delay, which includes ...